Literature DB >> 17043874

Histological response to injected dextranomer-based implant in a rat model.

Murat Alkan1, Arbay O Ciftci, Beril Talim, Mehmet E Senocak, Melda Caglar, Nebil Buyukpamukcu.   

Abstract

To investigate the short and long term histopathological alterations caused by submucosal injection of dextranomers in sodium hyaluronan (DiHA) based on an experimental rat model. Sixty Sprague-Dawley rats were assigned into two groups as group I and II, each containing 30 rats. Totally 0.1 ml of saline solution and 0.1 ml of DiHA were injected into the submucosa of bladder of first (control) and second groups, respectively. Both group I and II were further subdivided into three other groups as Group IA, IB, IC and Group IIA, IIB, IIC according to the sacrificial period. Group IA and IIA, IB and IIB, IC and IIC rats (ten rats for each group) were sacrificed 3, 6, and 12 months after surgical procedure, respectively. Two slides prepared from injection site of the bladder were evaluated completely for each rat by being unaware of the groups and at random by two independent senior pathologists to determine the fibroblast invasion, collagen formation, capillary growth and inflammatory reaction. Additionally, randomized brain sections from each rat were also examined to detect migration of the injection material. The measurements were made using an ocular micrometer at 10x magnification. The results were assessed using t-tests for paired and independent samples, with P<0.05 considered to indicate significant differences; all values were presented as the mean (SD). Migration to the brain was not detected in any group. Significant histopathological changes in the DiHA injected groups were granuloma formation in 43.3%, foreign body type giant cells in 76.6%, inflammatory infiltration in 100%, and fibroblasts surrounding microspheres in 100% of the rat bladder. The interaction between granuloma formation and long-term tissue effects in children is still obscure. We emphasize that further prospective human (and/or animal) studies are required to clarify the long-term effects of granuloma formation with regard to clinical applications.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043874     DOI: 10.1007/s00383-006-1818-1

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  32 in total

1.  Injectable dextranomer-based implant: histopathology, volume changes and DNA-analysis.

Authors:  A Stenberg; E Larsson; A Lindholm; B Ronneus; A Stenberg; G Läckgren
Journal:  Scand J Urol Nephrol       Date:  1999-12

Review 2.  Endoscopic treatment of children with vesico-ureteric reflux.

Authors:  G Läckgren; N Wåhlin; A Stenberg
Journal:  Acta Paediatr Suppl       Date:  1999-11

3.  Endoscopic treatment of vesico-ureteral reflux: twelve years' experience.

Authors:  N Capozza; M Patricolo; A Lais; E Matarazzo; P Caione
Journal:  Urol Int       Date:  2001       Impact factor: 2.089

4.  Endoscopic treatment of reflux: migration of Teflon to the lungs and brain.

Authors:  I A Aaronson; R A Rames; W B Greene; L G Walsh; U A Hasal; P D Garen
Journal:  Eur Urol       Date:  1993       Impact factor: 20.096

5.  Pulmonary Teflon granulomas following periurethral Teflon injection for urinary incontinence.

Authors:  R E Mittleman; J V Marraccini
Journal:  Arch Pathol Lab Med       Date:  1983-11       Impact factor: 5.534

6.  Endoscopic treatment of vesicoureteral reflux: 11 to 17 years of followup.

Authors:  Boris Chertin; Eric Colhoun; Murugesh Velayudham; Prem Puri
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

7.  Endoscopic treatment of vesicoureteral reflux in children.

Authors:  J Ortenberg
Journal:  Urol Clin North Am       Date:  1998-02       Impact factor: 2.241

8.  A new bioimplant for the endoscopic treatment of vesicoureteral reflux: experimental and short-term clinical results.

Authors:  A Stenberg; G Läckgren
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

9.  Endoscopic treatment with dextranomer-hyaluronic acid for vesicoureteral reflux: histological findings.

Authors:  A Stenberg; E Larsson; G Läckgren
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

10.  Endoscopic subureteral collagen injection for the treatment of vesicoureteral reflux in infants and children.

Authors:  P Frey; N Lutz; P Jenny; B Herzog
Journal:  J Urol       Date:  1995-08       Impact factor: 7.450

View more
  4 in total

1.  Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment.

Authors:  Göran Läckgren; Arne Stenberg
Journal:  Ther Adv Urol       Date:  2009-08

2.  Efficacy and safety of newly developed cross-linked dextran gel injection for glans penis augmentation with a novel technique.

Authors:  Dae Yul Yang; Kyungtae Ko; Seong Ho Lee; Du Geon Moon; Jong Wook Kim; Won Ki Lee
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

3.  Effects of PMMA and Cross-Linked Dextran Filler for Soft Tissue Augmentation in Rats.

Authors:  Jung-Bo Huh; Joo-Hyun Kim; Soyun Kim; So-Hyoun Lee; Kyung Mi Shim; Se Eun Kim; Seong Soo Kang; Chang-Mo Jeong
Journal:  Int J Mol Sci       Date:  2015-12-01       Impact factor: 5.923

4.  Endoscopic, Ultrasonographic, and Histologic Descriptions of Dextranomer/Hyaluronic Acid in a Case of Fecal Incontinence.

Authors:  Trent Irwin; Alexandria R Snow; Taylor S Orton; Christie Elliott
Journal:  Case Rep Pathol       Date:  2018-07-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.